3,6-DIOXA-1,8-OCTANEDITHIOL
Suppliers
Names
[ CAS No. ]:
14970-87-7
[ Name ]:
3,6-DIOXA-1,8-OCTANEDITHIOL
[Synonym ]:
Ethanethiol, 2,2'-(1,2-ethanediylbis(oxy))bis-
Ethanethiol, 2,2'-[1,2-ethanediylbis(oxy)]bis-
1,2-Bis(2-mercaptoethoxy)ethane,3,6-Dioxa-1,8-octane-dithiol
2,2'-[1,2-Ethanediylbis(oxy)]diethanethiol
3,6-DIOXA-1,8-OCTANEDITHIOL
2-[2-(2-sulfanylethoxy)ethoxy]ethanethiol
2,2'-(1,2-Ethanediylbis(oxy))bis(ethanethiol)
MFCD00015873
2,2'-[Ethane-1,2-diylbis(oxy)]diethanethiol
2,2'-(Ethylenedioxy)diethanethiol
EINECS 239-044-2
1,2-Bis(2-mercaptoethoxy)ethane
Ethylene Glycol Bis(2-mercaptoethyl) Ether
1,8-Dimercapto-3,6-dioxaoctane
Chemical & Physical Properties
[ Density]:
1.1±0.1 g/cm3
[ Boiling Point ]:
257.0±30.0 °C at 760 mmHg
[ Molecular Formula ]:
C6H14O2S2
[ Molecular Weight ]:
182.304
[ Flash Point ]:
109.2±24.6 °C
[ Exact Mass ]:
182.043518
[ PSA ]:
96.06000
[ LogP ]:
0.95
[ Vapour Pressure ]:
0.0±0.5 mmHg at 25°C
[ Index of Refraction ]:
1.495
MSDS
Safety Information
[ Symbol ]:
GHS07, GHS09
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H302 + H332-H411
[ Precautionary Statements ]:
P273
[ Personal Protective Equipment ]:
Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter
[ Hazard Codes ]:
T: Toxic;
[ Risk Phrases ]:
R22
[ Safety Phrases ]:
S26-S45
[ RIDADR ]:
UN 2810 6.1/PG 3
[ WGK Germany ]:
2
[ HS Code ]:
2930909090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2930909090
[ Summary ]:
2930909090. other organo-sulphur compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%
Articles
Biomaterials 35(22) , 5760-70, (2014)
N-(2-hydroxypropyl)-methacrylamide (HPMA) copolymers have shown promise for application in the detection and staging of cancer. However, non-target accumulation, particularly in the liver and spleen, ...
J. Pharm. Sci. 104(2) , 464-75, (2015)
For active cell targeting, viruses frequently capitalize on dual-receptor binding. With the intention to mimic this natural process, a dual peptide-based approach for targeting cancer cells was evalua...
Biomaterials 35(36) , 9719-30, (2014)
Despite the recent expansion of peptide drugs, delivery remains a challenge due to poor localization and rapid clearance. Therefore, a hydrogel-based platform technology was developed to control and s...